Dual Diagnosis Self-Help Referral

Dual Diagnosis Clinical Trial

Official title:

Dual Diagnosis Self-Help Group Referral: Outcomes and Services Use

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00286728
• Other study ID #: IIR 05-014
• Status: Completed
• Phase: N/A
• Start date: April 2006
• Est. completion date: September 2010

Study information

• Verified date: April 2019
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.

Description:

Background:

Dual diagnosis (psychiatric and substance use) patients' (DDPs) participation in 12-step mutual-help groups is linked to lower relapse and treatment utilization rates. However, under usual referral, many DDPs do not attend, or sustain attendance of, substance-focused groups (SFG). DDPs may benefit from dual-focused groups (DFGs).

Objectives:

(1) Implement and validate procedures to help counselors make effective referrals to DFGs. DDPs were assigned to a standard- or intensive-referral to DFG condition to determine the extent to which intensive referral, compared to standard referral, increased patients' mutual-help group participation. (2) Determine whether DDPs who received intensive referral had better substance use and psychiatric outcomes.

Methods:

DDPs entering VA outpatient mental health treatment received either standard (N=145) or intensive (N=142) referral. Standard referral consisted essentially of the counselor recommending DFG participation. The keys to intensive referral were a DFG orientation and the counselor facilitating direct contact between the patient and a DFG member, and following up on recommendations for mutual help. Patients were followed at six months (80%), one year (81%) and two years (80%) to determine whether intensive referral resulted in more DFG and SFG participation, and better substance use and psychiatric outcomes.

Status:

Completed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 287
• Est. completion date: September 2010
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Dually diagnosed veterans entering outpatient mental health treatment

Exclusion Criteria:

• Unable to correctly answer the Orientation and Registration questions of the Mini-Mental State Examination

Related Conditions & MeSH terms

• Dual Diagnosis

Intervention

Behavioral:
• Intensive referral to dual-focused self-help
4 group sessions to introduce patients to dual focused groups

Locations

Country	Name	City	State
United States	VA Palo Alto Health Care System, Palo Alto, CA	Palo Alto	California

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

References & Publications (4)

Makin-Byrd K, Cronkite RC, Timko C. The influence of abuse victimization on attendance and involvement in mutual-help groups among dually diagnosed male veterans. J Subst Abuse Treat. 2011 Jul;41(1):78-87. doi: 10.1016/j.jsat.2011.02.001. Epub 2011 Mar 10 — View Citation

Timko C, Cronkite RC, McKellar J, Zemore S, Moos RH. Dually diagnosed patients' benefits of mutual-help groups and the role of social anxiety. J Subst Abuse Treat. 2013 Feb;44(2):216-23. doi: 10.1016/j.jsat.2012.05.007. Epub 2012 Jul 3. — View Citation

Timko C, Sutkowi A, Moos R. Patients with dual diagnoses or substance use disorders only: 12-step group participation and 1-year outcomes. Subst Use Misuse. 2010 Mar;45(4):613-27. doi: 10.3109/10826080903452421. — View Citation

Timko C. Detoxification history and two-year outcomes of substance use disorder treatment and mutual-help group participation. Journal of drug issues. 2013 Jun 17; 20(10):1-18.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Psychiatric Functioning at 6 Months	Addiction Severity Index psychiatric composite ranges from 0 to 1, with 1 indicating more severe problems.	6 months
Secondary	Mental Health Services Use and Costs at 6 Months, 1 Year, and 2 Years		6 months, 1 year, 2 years